Literature DB >> 169868

Serum antibody responses to an ascitic variant of rat hepatoma D23.

R A Robins.   

Abstract

Antibody was detected by membrane immunofluorescence tests in sera of rats bearing an ascitic variant of a transplanted hepatoma, and in concentrated cell-free ascitic fluid. Ascites hepatoma cells were also shown to have immunoglobulin, possibly tumour specific antibody, bound to their surface. The kinetics of antibody responses to ascites hepatoma and hepatoma cells from solid tumours were compared: both tumour types gave positive reactions by the third day after implantation; antibody was present throughout subsequent tumour growth with the ascites whereas antibody was not detected after tumour became palpable in rats injected with hepatoma cells from solid tumour. Antibody responses to ascites tumour were investigated in rats bearing solid hepatoma tumour. Subcutaneous hepatoma did not influence the antibody response to ascites, but rats bearing intraperitoneal tumours showed a diminished serum antibody response to ascitic hepatoma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169868      PMCID: PMC2024795          DOI: 10.1038/bjc.1975.129

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

2.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

3.  Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas.

Authors:  R W Baldwin; M J Embleton
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

4.  Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.

Authors:  R W Baldwin; M J Embleton; R A Robins
Journal:  Int J Cancer       Date:  1973-01-15       Impact factor: 7.396

5.  Tumour-specific antigenicity of aminoazo-dye-induced rat hepatomas.

Authors:  R W Baldwin; C R Barker
Journal:  Int J Cancer       Date:  1967-07-15       Impact factor: 7.396

6.  Globulin coating in vivo of Ehrlich's ascites carcinoma cells.

Authors:  S Thunold
Journal:  Transplantation       Date:  1968-08       Impact factor: 4.939

7.  Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.

Authors:  R W Baldwin; C R Barker
Journal:  Br J Cancer       Date:  1967-12       Impact factor: 7.640

8.  Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum.

Authors:  R W Baldwin; J G Bowen; M R Price
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640

  8 in total
  4 in total

1.  Comparison of DMSO and glycerol as cryoprotectants for ascites tumor cells.

Authors:  S A Shah
Journal:  Experientia       Date:  1983-03-15

2.  Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity.

Authors:  D Hannant; J G Bowen; M R Price; R W Baldwin
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

3.  BCG treatment of malignant pleural effusions in the rat.

Authors:  M V Pimm; D G Hopper; R W Baldwin
Journal:  Br J Cancer       Date:  1976-10       Impact factor: 7.640

4.  Non-immunogenicity of enucleated rat hepatoma cells in syngeneic animals.

Authors:  D Gerlier; M Price; R W Baldwin
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.